Alan E. SalzmanManaging Partner
Alan co-founded VantagePoint Capital Partners in 1996 and serves as CEO and Chair of the Investment Committee. As a leading venture investor for over 20 years, Salzman has had hands-on involvement in more than 300 companies and has held overall management responsibilities for a dozen venture funds with over $5 billion of committed capital. As CEO of VantagePoint, he oversees the investment team, a portfolio of innovative companies, and strategic partnerships with a number of leading corporations. Salzman is a frequent contributor and speaker on energy innovation and efficiency, entrepreneurship and global competiveness. He has served as Finance Chair of the World Business Summit on Climate Change, on the BP Alternative Energy Advisory Board, and held a decade-long faculty appointment as Adjunct Professor for Venture Capital and Entrepreneurial Companies at Stanford University. He currently serves on the Leadership Council of The Climate Group, the World Economic Forum Technology Pioneer Selection and Green Investment Committees, and the Board of Directors of the Silicon Valley Leadership Group. He is a graduate (G.C., B.A., J.D., LLM) of the London School of Economics, the University of Toronto, Stanford Law School and the Vrije Universiteit Brussel.
“Entrepreneurs are the engine of innovation in this country. CleanTech and the technology at the heart of CleanTech will transform the current century.”
—Alan E. Salzman
Lee BurrowsManaging Director
Lee joined VantagePoint in 2002, bringing with him 15 years of broad semiconductor technology expertise, specifically in the areas of semiconductor processing, advanced materials, power storage and management, and battery, lighting, and smart grid technologies. Previously, he founded an optical component company that was subsequently acquired by New Focus, a leading photonics solutions provider. Lee holds six patents, with two additional patents pending in optical networking and device manufacturing. He graduated with honors from the California Institute of Technology (BS, MS) and is also a candidate for a PhD in Applied Physics.
“VantagePoint's team orientation helps us make better investment decisions and is a real value-add to our portfolio companies.”
Thomas HuotManaging Director
Thomas joined VantagePoint in 2004 focusing on biopharmaceutical and medical device investments. He currently has a primary emphasis in the areas of biofuels and biomaterials. Prior to VantagePoint, he was an Analyst with CDP Capital Technology Ventures, where he developed new fields of investment in the areas of diabetes and metabolic diseases. Earlier in his career, Thomas served as Project Manager for Genopole®, a business incubator specializing in the development of biology on a large scale and the creation of biotechnology companies responsible for conducting technical and economic feasibility studies. Thomas graduated from the University of London. He holds a Ph.D. in Biochemistry and Molecular Biology from University College London and a B.Sc. in Biochemistry from University Paris XI, Orsay.